Health Care & Life Sciences » Pharmaceuticals | Acura Pharmaceuticals Inc.

Acura Pharmaceuticals Inc.

Acura Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.26
Market Cap
$5.66 M
Shares Outstanding
21.03 M
Public Float
7.21 M

Profile

Address
616 N. North Court
Palatine Illinois 60067
United States
Employees -
Website http://www.acurapharm.com
Updated 07/08/2019
Acura Pharmaceuticals, Inc. operates as a pharmaceutical company, which engages in the research, development and commercialization of products intended to address medication abuse and misuse, utilizing its proprietary aversion and impede technologies. It operates its business through the research, development, and manufacture of innovative abuse deterrent, orally administered pharmaceutical products. The company was founded in 1935 and is headquartered in Palatine, IL.

Financials

View All
Created with Highcharts 5.0.14Acura Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.13 90113 90113 20913 2094 9894 9897 3887 3885 6825 6822013201420152016201702.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Acura Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.1231237517518 5878 5874 4644 4642 9662 9662013201420152016201702k4k6k8k10k

Robert B. Jones
President, Chief Executive Officer & Director
George K. Ross
Independent Director